Pulse Journal Club Trending Explore Questions Researchers

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Privacy Policy

Home Explore Journal Club Trending

⌘+K

Glucocorticoids plusN-Acetylcysteine in Severe Alcoholic Hepatitis | Synapse

November 9, 2011Open Access

Glucocorticoids plusN-Acetylcysteine in Severe Alcoholic Hepatitis

Key Points

Key points are not available for this paper at this time.

Abstract

Although combination therapy with prednisolone plus N-acetylcysteine increased 1-month survival among patients with severe acute alcoholic hepatitis, 6-month survival, the primary outcome, was not improved. (Funded by Programme Hospitalier de Recherche Clinique; AAH-NAC ClinicalTrials.gov number, NCT00863785 .).

Read Full Paperexternally

Mark Helpful

Bookmark

Relay

View Full Paper

Mark Helpful

Bookmark

Relay

View Full Paper

Cite This Study

Nguyen-Khac et al. (Wed,) studied this question.

synapsesocial.com/papers/69d722a5a98988943d5637cd https://doi.org/https://doi.org/10.1056/nejmoa1101214

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor2009 · 365 citations
2Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?2003 · 225 citations
3Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone2003 · 132 citations
4Improvement in renal function in hepatorenal syndrome with N-acetylcysteine1999 · 171 citations
5Time to Initiation of Antiretroviral Therapy Among Patients With HIV-Associated Tuberculosis in Cape Town, South Africa2011 · 31 citations